Home
About
Overview
Sharing Data
ORCID
Help
History (16)
Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial.
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up.
Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer.
What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?
Development and clinical indications of cetuximab.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Development and clinical indications of cetuximab.
Development and clinical indications of cetuximab. Int J Biol Markers. 2007 Jan-Mar; 22(1 Suppl 4):S40-6.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bevacizumab
Biomarkers, Tumor
Camptothecin
Cetuximab
Colorectal Neoplasms
Drug Resistance, Neoplasm
ErbB Receptors
Humans
Immunohistochemistry
authors with profiles
Marina Chiara Garassino